These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35051691)

  • 1. Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma.
    Ikeda K; Kolakshyapati M; Takayasu T; Amatya VJ; Takano M; Yonezawa U; Taguchi A; Onishi S; Takeshima Y; Sugiyama K; Yamasaki F
    Eur J Radiol; 2022 Feb; 147():110103. PubMed ID: 35051691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma.
    Yamasaki F; Nishibuchi I; Karakawa S; Kaichi Y; Kolakshyapati M; Takano M; Yonezawa U; Imano N; Taguchi A; Shimomura M; Taniguchi M; Onishi S; Okada S; Awai K; Sugiyama K; Nagata Y
    Pediatr Neurosurg; 2021; 56(1):1-9. PubMed ID: 33535215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
    Kurokawa R; Kurokawa M; Baba A; Ota Y; Kim J; Capizzano A; Srinivasan A; Moritani T
    Eur Radiol; 2022 Jun; 32(6):3672-3682. PubMed ID: 35022811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcome in childhood diffuse midline gliomas using magnetic resonance imaging based texture analysis.
    Szychot E; Youssef A; Ganeshan B; Endozo R; Hyare H; Gains J; Mankad K; Shankar A
    J Neuroradiol; 2021 Jun; 48(4):243-247. PubMed ID: 32184119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.
    Raab P; Banan R; Akbarian A; Esmaeilzadeh M; Samii M; Samii A; Bertalanffy H; Lehmann U; Krauss JK; Lanfermann H; Hartmann C; Brüning R
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced MR imaging and
    Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffuse midline glioma].
    Saito R
    No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
    Banan R; Akbarian A; Samii M; Samii A; Bertalanffy H; Lehmann U; Hartmann C; Brüning R
    PLoS One; 2021; 16(8):e0249647. PubMed ID: 34347774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review.
    Sugii N; Ninomiya Y; Akimoto Y; Tsurubuchi T; Ishikawa E
    Radiol Case Rep; 2024 Jan; 19(1):200-206. PubMed ID: 38028289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic findings and the molecular expression profile of diffuse midline glioma H3 K27M mutant.
    Seong M; Kim ST; Noh JH; Kim YK; Kim HJ
    Acta Radiol; 2021 Oct; 62(10):1404-1411. PubMed ID: 33175579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.
    Li Q; Dong F; Jiang B; Zhang M
    Front Oncol; 2021; 11():646267. PubMed ID: 34109112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
    Jiang H; Yang K; Ren X; Cui Y; Li M; Lei Y; Lin S
    Neuro Oncol; 2020 May; 22(5):e1-e9. PubMed ID: 31504810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.
    Chen H; Hu W; He H; Yang Y; Wen G; Lv X
    Eur J Radiol; 2019 May; 114():152-159. PubMed ID: 31005167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
    Dono A; Takayasu T; Ballester LY; Esquenazi Y
    J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-Growing Thalamic Glioma with Histone H3 Lysine 27-to-Methionine Mutation: 3-Year Follow-Up Before Surgical Intervention.
    Chanchotisatien A; Pan J; Du Z; Qiu T; Yu J; Chu S
    World Neurosurg; 2019 Jul; 127():266-268. PubMed ID: 30981797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma.
    Park J; Chung C
    Brain Tumor Res Treat; 2023 Apr; 11(2):86-93. PubMed ID: 37151150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse midline glioma H3 K27M-mutant in adults: A report of six cases and literature review.
    Alzoubi H; Maraqa B; Hasasna N; Giangaspero F; Antonelli M; Gianno F; Arcella A; Al-Hussaini M
    Clin Neuropathol; 2021; 40(2):108-117. PubMed ID: 33191898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.
    Vitanza NA; Biery MC; Myers C; Ferguson E; Zheng Y; Girard EJ; Przystal JM; Park G; Noll A; Pakiam F; Winter CA; Morris SM; Sarthy J; Cole BL; Leary SES; Crane C; Lieberman NAP; Mueller S; Nazarian J; Gottardo R; Brusniak MY; Mhyre AJ; Olson JM
    Neuro Oncol; 2021 Mar; 23(3):376-386. PubMed ID: 33130903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin.
    Gilbert AR; Zaky W; Gokden M; Fuller CE; Ocal E; Leeds NE; Fuller GN
    Pediatr Neurosurg; 2018; 53(1):59-63. PubMed ID: 29131126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.